Form 483

Tarmac Products, Inc. Form 483, 2015-01-08

FDA issued a Form 483 to Tarmac Products, Inc. on 2015-01-08 with 10 public-safe observations.

483· Form 483 issuedHuman Drugs10 observations

Tarmac Products, Inc. · Miami Gardens, United States · Issued January 8, 2015

Overview

  • 10 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Jan 2015
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Ileana Barreto-Pettit

8 Jan 2015
21 CFR 211.165(a)

Testing and release for distribution

Cited by Ileana Barreto-Pettit

8 Jan 2015
21 CFR 211.166(a)

Written program not followed

Cited by Ileana Barreto-Pettit

8 Jan 2015
21 CFR 211.180(e)(1)

Review of representative number of batches

Cited by Ileana Barreto-Pettit

8 Jan 2015
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Ileana Barreto-Pettit

Inspected site

TPTarmac Products, Inc.Miami Gardens, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(b)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 10 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere